Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-06-12

FDA Approved: ISOPROTERENOL — Original Application (Cipla USA Inc.)

View source ↗

Summary

FDA approves Cipla's original application for isoproterenol hydrochloride (generic) injection, expanding available generic options.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isoproterenol hydrochloride (Isoproterenol hydrochloride)

Snippet

ORIG AP for ISOPROTERENOL (ISOPROTERENOL HYDROCHLORIDE)